Ocular effects of pegylated interferon-α in patients with chronic hepatitis B

Cutaneous and Ocular Toxicology

Volumn 32, Issue 4, 2013, Pages 275-278

  Koktekir, Bengu Ekinci ^a   Sumer, Sua ^a   Bakbak, Berker ^a   Gedik, Sansal ^a   Gonul, Saban ^a   Ural, Onur ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis B; Pegylated interferon ; Retinal nerve fiber layer; Visual field

Indexed keywords

PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGYLATED INTERFERON ALPHA 2A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE STUDY; CHRONIC HEPATITIS B; CLINICAL ARTICLE; COLOR VISION; COMPARATIVE STUDY; CONTROLLED STUDY; DRY EYE; EYE FUNDUS; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOTHERAPY; MALE; MONOTHERAPY; NERVE FIBER; OPHTHALMOLOGICAL EQUIPMENT; OPTIC DISK; PERIMETRY; PROSPECTIVE STUDY; RETINA; RETINAL NERVE FIBER LAYER THICKNESS; SCHIRMER TEST;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NERVE FIBERS; POLYETHYLENE GLYCOLS; RETINA; VISUAL FIELDS;

EID: 84883138490     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2013.775656     Document Type: Article

References (20)

1. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigennegative chronic hepatitis B: Natural history and treatment. Semin Liver Dis 2006;26:130-41
2. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507-39
3. Sonneveld MJ, Janssen HL. Chronic hepatitis B: Peginterferon or nucleos(t)ide analogues? Liver Int 2011;31:78-84
4. Kim ET, Kim LH, Lee JI, Chin HS. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. Jpn J Ophthalmol 2009;53:598-602
5. Quesada JR, Talpaz M, Rios A, et al. Clinical toxicity of interferon in cancer patients: A review. J Clin Oncol 1986;4: 234-43
6. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350-6
7. Hayasaka S, Nagaki Y, Matsumodto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol 1998;82:323-5
8. Willson RL, Ross RD, Willson LM, et al. Interferon-associated retinopathy in a young, insulin-dependent diabetic patient. Retina 2000;20:413-15
9. Schulman L, Kooragayala K. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003;110:437-42
10. Nagaoka T, Sato E, Takahashi A, et al. Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C. Invest Ophthalmol Vis Sci 2007;48: 368-75
11. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995;113:1041-4
12. Ayaki M. Development of neovascular glaucoma in the course of interferon alfa therapy for hepatitis C. Br J Ophthalmol 1994; 78:238
13. Wall M, Neahring RK, Woodward KR. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: A comparison with conventional automated perimetry. Invest Ophthalmol Vis Sci 2002;43:1277-83
14. Manesis EK, Petrou C, Brouzas D, Hadziyannis S. Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 1994;21:474-7
15. Ikebe T, Nakatsuka K, Goto M. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn 1190;41:2291-6
16. Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol 2004;88:1518-20
17. d'Alteroche L, Majzoub S, Lecuyer AI, et al. Ophthalmic side effects during alfa-interferon therapy for viral hepatitis. J Hepatol 2006;44:56-61
18. Berg KT, Nelson B, Harrison AR, et al. Peyglated interferon alphaassociated optic neuropathy. J Neuroophthalmol 2010;30:117-22
19. Van Wie AM. Hepatitis C and interferon-associated retinopathy: A case report. Optometry 2011;82:739-43
20. Oishi A, Miyamoto K, Kashii S, Yoshimura N. Abducens palsy and Sjögren' syndrome induced by pegylated interferon therapy. Br J Ophthalmol 2007;91:843-4